SuperworthPraxis Precision Medicines shares outstanding PRAX
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 29.1M
- On a year earlier
- +35.7%
- more shares
Praxis Precision Medicines had 29.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 35.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 25.5M | +27% |
| FY2024 | 20M | +121% |
| FY2023 | 9.1M | +186% |
| FY2022 | 3.2M | +6% |
| FY2021 | 3M | +2690% |
| FY2019 | 107.5K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 29.1M | +36% | |
| Q1 FY26 | 28.9M | +37% | |
| Q4 FY25 | 25.5M | +27% | |
| Q3 FY25 | 22M | +16% | |
| Q2 FY25 | 21.5M | +14% | |
| Q1 FY25 | 21.1M | +51% | |
| Q4 FY24 | 20M | +121% | |
| Q3 FY24 | 18.9M | +109% | |
| Q2 FY24 | 18.8M | +305% | |
| Q1 FY24 | 13.9M | +293% | |
| Q4 FY23 | 9.1M | +186% | |
| Q3 FY23 | 9M | +196% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Praxis Precision Medicines
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.